Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02499965 · ClinicalTrials.gov registry record · NA
Skin Refrigerant to Reduce the Pain Associated With IV Insertion
A NA study, sponsored by Brooke Army Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 38
- Enrollment target
NCT02499965: Completed NA study, sponsored by Brooke Army Medical Center.
NCT02499965 is a NA study that has completed, run by Brooke Army Medical Center. The registered enrollment target is 38 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02499965, a NA study, has completed, sponsored by Brooke Army Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether or not the pain of IV catheter insertion in the Emergency Department can be reduced significantly with the use of a rapid acting topical anesthetic spray and to determine whether or not healthcare providers who undergo such treatment are likely to endorse its use in their future practice.
Primary Outcome
Ordinal pain scale (1-10)
Interventions
- DRUG Ethyl Chloride Topical Aerosol Anesthetic
- DRUG Nature's Tears Sterile Water
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2015-04 |
| Est. Completion | 2015-05 |
| Phase | NA |
What the finished NCT02499965 record still lists
NCT02499965 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 38 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Ethyl Chloride Topical Aerosol Anesthetic is the first listed.
NCT02499965 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02499965 about?
NCT02499965 is a clinical study titled "Skin Refrigerant to Reduce the Pain Associated With IV Insertion". The purpose of this study is to determine whether or not the pain of IV catheter insertion in the Emergency Department can be reduced significantly with the use of a rapid acting topical anesthetic spray and to determine whether or not healthcare providers who undergo such treatment are likely to en...
What is the current status of trial NCT02499965?
This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2015-04. Estimated completion is 2015-05.
What interventions are being tested in trial NCT02499965?
The interventions under investigation include: Ethyl Chloride Topical Aerosol Anesthetic (DRUG), Nature's Tears Sterile Water (DRUG).
Who is sponsoring clinical trial NCT02499965?
This trial is sponsored by Brooke Army Medical Center, which has 54 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02499965's enrollment target sits among peer trials
38 1538th of 2000 higher than 461 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01684904 · 38 participants · NA
Proton Therapy for Esophageal Cancer
- NCT03310879 · 38 participants · Phase 2
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
- NCT03896269 · 38 participants · Phase 1
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
- NCT04085315 · 38 participants · Phase 1
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia